Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Trisenox now available in Canada

Nov. 14, 2013

Canadian approval for Eylea in wet AMD

Nov. 14, 2013

Health Canada approves Opsumit for pulmonary arterial hypertension

Nov. 14, 2013

Health Canada approves Giotrif

Nov. 8, 2013

Health Canada approves Stivarga for gastrointestinal stromal tumors

Oct. 21, 2013

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

Bayer receives Canadian approval for riociguat in thromboembolic pulmonary hypertension

Sep. 26, 2013

Health Canada approves Roche's Erivedge for advanced basal cell carcinoma

Aug. 28, 2013

Jetrea approved for symptomatic vitreomacular adhesion in Canada

Aug. 19, 2013

Health Canada approves two GSK drugs for metastatic melanoma

July 25, 2013

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...